Drug
Azd-1446 clinical trials
Also written AZD1446.
- studies test it
- 11
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How studies write it
Studies that test it under each name
Development codes
- AZD1446
- 11
Studies by the year they started
11 studies that test it; most in 2009 (7)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2009 | 7 |
| 2010 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 0
Studies
Open first, then newest update. How each study uses azd-1446 is read from its arms, and is right about nine times in ten.
Testing it · 11
- Study to Investigate the Efficacy and Tolerability of AZD1446 in Adult ADHD Patients.CompletedPhase 2AstraZenecaNCT01012375Written as AZD1446
- To Evaluate Effects of AZD1446, Placebo and Donepezil in Patients With Alzheimer's DiseaseTerminatedPhase 2AstraZenecaNCT01125683Written as AZD1446
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of Modified-Release Formulations of AZD1446 After Oral Single and Repeated DosesCompletedPhase 1AstraZenecaNCT01199315Written as AZD1446
- A Bioavailability Study Comparing Modified-release Capsules and Immediate Release Capsules in Fed and Fasting ConditionsCompletedPhase 1AstraZenecaNCT01092299Written as AZD1446
- 4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's DiseaseCompletedPhase 2AstraZenecaNCT01039701Written as AZD1446
- Study to Assess Safety, Tolerability and Pharmacokinetics After Single and Multiple Doses of AZD1446 to Japanese SubjectCompletedPhase 1AstraZenecaNCT01021189Written as AZD1446
- A Healthy Volunteer Study to Evaluate Reversibility of Induced Impairment of CognitionCompletedPhase 1AstraZenecaNCT01044342Written as AZD1446
- A Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD1446 Administered for 4 Weeks in Elderly Healthy VolunteersCompletedPhase 1AstraZenecaNCT00997308Written as AZD1446
- Study to Investigate Safety, Tolerability and Pharmacokinetics With Single and Multiple Ascending Doses of AZD1446CompletedPhase 1AstraZenecaNCT00902993Written as AZD1446
- Positron Emission Tomography (PET) StudyCompletedPhase 1AstraZenecaNCT00886067Written as AZD1446
- Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD1446 to Healthy VolunteersCompletedPhase 1AstraZenecaNCT00803855Written as AZD1446